TrialJournal of child and adolescent psychopharmacology2022

Long-Term Safety and Efficacy of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 52-Week, Multicenter, Open-Label Extension Study.

Takuya Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.